NCT00238199View on ClinicalTrials.gov

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Pancreatic Cancer
Interventions
DIETARY_SUPPLEMENT

calcitriol

DRUG

docetaxel

Trial Locations (1)

97239-3098

Oregon Health & Science University Cancer Institute, Portland

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

OHSU Knight Cancer Institute

OTHER

NCT00238199 - Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter